Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Future Oncology (London, England)|October 14, 2021
Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiariesKarl M Kilgore, Iman Mohammadi, Anny C Wong, et al.Blood|June 20, 2023
Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphomaDai Chihara, Laura Liao, Joseph Tkacz, et al.Archives of Physical Medicine and Rehabilitation|October 1, 1992
Applying psychometric criteria to functional assessment in medical rehabilitation: III. Construct validity and predicting level of careR F Harvey, B Silverstein, M A Venzon, et al.Pediatric Pulmonology|March 8, 2018
Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosisHeather S Kirkham, Francis Staskon, Nishita Hira, et al.Journal of Virology|December 18, 2015
Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus MacaquesS Abigail Smith, Katie M Kilgore, Sudhir Pai Kasturi, et al.The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Regulation of expression of the genes encoding steroidogenic enzymesE Simpson, M Lauber, M Demeter, et al.Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1975
Pharmacodynamic distinctions between ouabain, digoxin and digitoxinT M Runge, J C Stephens, P Holden, et al.Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society|July 1, 1993
Two-component arterial blood pressure conditional response in ratD C Randall, D R Brown, L V Brown, et al.Plos Pathogens|March 16, 2019
Central memory CD8+ T cells become CD69+ tissue-residents during viral skin infection independent of CD62L-mediated lymph node surveillanceJossef F Osborn, Samuel J Hobbs, Jana L Mooster, et al.Transplantation and Cellular Therapy|May 2, 2024
Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment CentersNausheen Ahmed, Fang Sun, Christie Teigland, et al.Pageof 6